Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 13/20 | 0.47 |
| ▸ | MMP9 | P14780 | 13/20 | 0.47 |
| ▸ | MMP3 | P08254 | 13/20 | 0.45 |
| ▸ | MMP2 | P08253 | 3/20 | 0.44 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | CTSL | P07711 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Leucine SCHEMBL6412363 | 0.93 | MMP1 (0.53) | MMP1MMP9MMP3MMP2ELANE | |
| SCHEMBL7329031 | 0.90 | TDP1 (0.49) | MMP1MMP9MMP3TDP1L3MBTL1 | |
| SCHEMBL6843799 | 0.82 | TDP1 (0.58) | MMP1MMP9TDP1L3MBTL1 | |
| Leucine SCHEMBL8488907 | 0.80 | ELANE (0.44) | MMP1MMP9MMP3MMP2ELANE | |
| Leucine SCHEMBL7325651 | 0.79 | MMP3 (0.55) | MMP1MMP9MMP3MMP2 | |
| Leucine SCHEMBL6415429 | 0.79 | MMP3 (0.55) | MMP1MMP9MMP3MMP2 | |
| Leucine SCHEMBL7327425 | 0.76 | SLC1A3 (0.43) | MMP3MMP2CTSL | |
| Leucine SCHEMBL6421654 | 0.75 | MMP3 (0.62) | MMP1MMP9MMP3MMP2 | |
| Leucine SCHEMBL7371235 | 0.75 | MMP3 (0.62) | MMP1MMP9MMP3MMP2 | |
| SCHEMBL12087999 | 0.75 | CYP3A4 (0.53) | TDP1L3MBTL1CTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5932551-A | INHIBITORS OF MATRIX METALLOENDOPROTEINASE-MEDIATED DISEASES | MERCK & CO., INC. (US) | 1999-08-03 | — | — | US | disclosed |